Results 91 to 100 of about 8,269 (200)

ARE BONE MARROW MONOCYTE CHARACTERISTICS AT DIAGNOSIS INDICATIVE OF THE EVOLUTION OF MYELODYSPLASTIC NEOPLASMS TO CHRONIC MYELOMONOCYTIC LEUKEMIA?

open access: yesHematology, Transfusion and Cell Therapy
Background: The progression of myelodysplastic neoplasms (MDS) to chronic myelomonocytic leukemia (CMML) has been recognized since a long time. Several works have shown that 4.8% - 20% of patients with MDS may progress to CMML, depending on the criteria ...
Joyce Rico VIDO-MARQUES   +5 more
doaj   +1 more source

Determinants of Phenotypic Commitment and Clonal Progression--Conclusions from the Study of Clonal Architecture in CMML

open access: yes, 2015
CMML is heterogeneous clinically (a varying degree of dysplastic or proliferative clinical features) and in terms of its molecular pathogenesis. Analysis of the spectrum of genomic lesions in CMML may contribute to understanding of the pathogenesis and ...
Przychodzen, Bartlomiej   +27 more
core   +1 more source

Clinical management of CMML —State of the art

open access: yesBritish Journal of Haematology
Summary Chronic myelomonocytic leukaemias (CMML) are myeloid neoplasms characterized by a sustained increase in monocyte counts in the peripheral blood, accompanied by dysplasia, abnormal proliferation, chromosomal anomalies and somatic mutations of haematopoietic cells. More than 95% of CMML patients harbour somatic mutations.
K. Nachtkamp   +3 more
openaire   +3 more sources

Clinical perception and novel insights of chronic myelomonocytic leukemia: a 10-year multi-center retrospective study

open access: yesFrontiers in Medicine
Background and objectiveChronic myelomonocytic leukemia (CMML) is a malignant clonal disorder characterized by both myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (MPN) features.
Yanquan Liu   +8 more
doaj   +1 more source

Prognostic Significance and Treatment Response Associations of Genetic Mutations in Chronic Myelomonocytic Leukemia: A Retrospective Cohort Study

open access: yesBiomedicines
Background: This retrospective cohort study investigates the prognostic significance of genetic mutations in Chronic Myelomonocytic Leukemia (CMML) and their association with treatment responses among patients treated at a single institution, juxtaposed ...
Jing Di   +7 more
doaj   +1 more source

Design of LNA Analogues Using a Combined Density Functional Theory and Molecular Dynamics Approach for RNA Therapeutics

open access: yesACS Omega, 2023
Dikshita Dowerah   +8 more
doaj   +1 more source

Extramedullary Manifestations of Chronic Myelomonocytic Leukemia: Do We Treat like an Acute Myeloid Leukemia?

open access: yesCase Reports in Hematology, 2019
Chronic myelomonocytic leukemia (CMML) is a relatively rare clonal hematologic disorder with features of myelodysplastic syndrome and myeloproliferative disease. Extramedullary leukemic involvement is rarely a presenting feature of CMML.
Prasun Pudasainee   +4 more
doaj   +1 more source

Analysis of differentially methylated genes in CMML samples with and without TET2 mutations.

open access: yes, 2012
A) Hierarchical cluster analysis based on abnormally methylated genes between CMML samples with TET2 mutations and CMML samples without TET2 mutations.
Jacqueline Boultwood (89560)   +16 more
core   +1 more source

Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML

open access: yes, 2017
Key Points Genetically accurate xenografts of CMML are achievable with near 100% frequency in NSGS mice. Robust human engraftment and overt phenotypes of CMML and JMML xenografts here facilitate preclinical therapeutic evaluation in vivo.
Lu, Sydney X   +51 more
core   +1 more source

Answers for the CME: CMML

open access: yesThe Sri Lanka Journal of Haematology
No abstract ...
openaire   +1 more source

Home - About - Disclaimer - Privacy